Compare Boston Scientific Corporation (BSX) vs SAP SE (SAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs SAP SE — how do they compare? Boston Scientific Corporation trades at $51.1 (market cap $74.19B), while SAP SE trades at $206.23 (market cap $240.81B). The key difference: SAP SE is far larger — about 3.2× Boston Scientific Corporation's market cap, and SAP SE pays a 1.4% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | SAP | |
|---|---|---|
Market Cap | $74.19B | $240.81B |
Sector | Health | Technology |
52-Week High | $108.14 | $280.46 |
52-Week Low | $42.63 | $146.38 |
Enterprise Value | $86.27B | $239.52B |
Dividend Yield | — | 1.4% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About SAP SE
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →
